Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation
US-9770349-B2 · Sep 26, 2017 · US
US11866627B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11866627-B2 |
| Application number | US-202117192388-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 4, 2021 |
| Priority date | Jun 2, 2020 |
| Publication date | Jan 9, 2024 |
| Grant date | Jan 9, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A quantum dot composition includes a quantum dot, and a ligand bonded to a surface of the quantum dot, wherein the ligand includes a head portion bonded to the surface of the quantum dot and containing a polar solvent dissociative functional group, and a tail portion connected to the head portion. A quantum dot composition according to an embodiment is used to form an emission layer of a light emitting element to enhance luminous efficiency of the light emitting element including an emission layer formed through the quantum dot composition.
Opening claim text (preview).
What is claimed is: 1. A quantum dot composition comprising: a quantum dot; and a ligand bonded to a surface of the quantum dot, wherein the ligand comprises: a head portion bonded to the surface of the quantum dot and containing a polar solvent dissociative functional group; and a tail portion connected to the head portion, the tail portion containing a non-polar organic material, and the ligand is represented by any one among Formulae 1 to 19, and 21 to 23: wherein in Formulae 1 to 19, and 21 to 23, R 1 and R 2 are each independently a substituted or unsubstituted alkyl group having 7 to 30 carbon atoms, or a substituted or unsubstituted aryl group having 6 to 30 ring-forming carbon atoms, and x 1 is an integer of 1 to 10. 2. The quantum dot composition of claim 1 , wherein the quantum dot comprises: a core; and a shell surrounding the core, and an interface between the core and the shell having a concentration gradient of an element that decreases toward the core. 3. The quantum dot composition of claim 1 , wherein the tail portion comprises a substituted or unsubstituted alkyl group having 7 to 30 carbon atoms, or a substituted or unsubstituted aryl group having 6 to 30 ring-forming carbon atoms. 4. The quantum dot composition of claim 1 , wherein the ligand is a monodentate ligand or a bidentate ligand. 5. The quantum dot composition of claim 1 , wherein the head portion comprises a hydrogen cation, a sodium cation, or a potassium cation. 6. The quantum dot composition of claim 1 , further comprising a non-polar organic solvent. 7. The quantum dot composition of claim 1 , wherein the tail portion has a first end connected to the head portion and a free second end opposite the first end. 8. A light emitting element comprising: a first electrode; a hole transport region on the first electrode; an emission layer on the hole transport region and containing a quantum dot and ligand residues, the ligand residues comprising a head portion and a tail portion connected to the head portion, the tail portion containing a non-polar organic material; an electron transport region on the emission layer; and a second electrode on the electron transport region, and wherein the head portion comprises a polar solvent dissociative functional group, and the ligand residues are dissociated from the quantum dots. 9. The light emitting element of claim 7 , wherein the quantum dot comprises: a core; and a shell surrounding the core, and an interface between the core and the shell having a concentration gradient of an element that decreases toward the core. 10. The light emitting element of claim 7 , wherein the ligand residues comprise at least one among a sulfonyl ion, a carbonyl ion, a phosphate ion, an ammonium ion, an oxy group, or an amine group. 11. The light emitting element of claim 7 , wherein the ligand residues comprise a substituted or unsubstituted alkyl group having 6 to 30 carbon atoms, or a substituted or unsubstituted aryl group having 6 to 30 ring-forming carbon atoms. 12. The light emitting element of claim 7 , wherein the ligand residues comprise a hydrogen cation, a sodium cation, or a potassium cation. 13. The light emitting element of claim 7 , wherein the ligand residues comprise aliphatic or aromatic hydrocarbons connected to the polar solvent dissociative functional group.
in the presence of solvent vapors, e.g. solvent vapour annealing · CPC title
containing organic luminescent materials · CPC title
of polyhydroxy compounds · CPC title
Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen · CPC title
Salts thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.